暫無數據
代碼股票名稱
最新價漲跌額漲跌幅成交量成交額今開昨收最高最低總市值流通市值總股本流通股本5日漲跌幅10日漲跌幅20日漲跌幅60日漲跌幅120日漲跌幅250日漲跌幅年初至今漲跌幅股息率TTM換手率市盈率TTM市盈率(靜)振幅所屬行業
美股期權個股詳情
OLN240517P57500
- 1.40
- 0.000.00%
延時15分鐘行情收盤價 05/14 13:13 (美東)
0.00最高價0.00最低價
0.00今開1.40昨收0張成交量0張未平倉合約數57.50行權價0.00成交額0.00%引伸波幅3.07%溢價2024/05/17到期日3.07内在价值100合約乘數-5天距到期日0.00時間價值100合約規模美式期權類型--Delta--Gamma38.88槓桿倍數--Theta--Rho--有效槓桿--Vega
分時
- 5日
- 日K
新聞
奧林高管帕特里克·舒馬赫定於2024年離職
快訊 | 紐約證券交易所訂單不平衡買入方有63751.0股股票
格隆匯5月15日｜歐林生物公告，四價流感病毒裂解疫苗(MDCK細胞)獲得藥物臨床試驗批准通知書。
格隆匯5月15日｜歐林生物公告，四價流感病毒裂解疫苗(MDCK細胞)獲得藥物臨床試驗批准通知書。
成都歐林生物科技股份有限公司藥品申請臨床試驗默示許可獲受理
5月15日，據CDE官網消息，成都新諾明生物科技有限公司、成都歐林生物科技股份有限公司、蘭州百靈生物技術有限公司聯合申請藥品“四價流感病毒裂解疫苗（MDCK細胞）”，獲得臨床試驗默示許可，受理號CXSL2400138。公示信息顯示，藥品“四價流感病毒裂解疫苗（MDCK細胞）”適應症：用於預防疫苗相關型別流感病毒引起的流行性感冒。
Olin Insiders出售了2200萬美元的股票，這表明他們猶豫不決
在過去的一年中，許多奧林公司（紐約證券交易所代碼：OLN）內部人士拋售了股票，這可能會引起該公司的股東的興趣。在分析內幕交易時，通常更有價值
快訊 | 紐約證券交易所訂單不平衡買入方有96764.0股票
評論
Olin's capital allocation skills are strong, yielding higher returns from less capital. The stock's 159% return over five years suggests investors acknowledge these positive changes. If trends persist, Olin's future looks promising.
The Return Trends At Olin (NYSE:OLN) Look Promising 1
The shift from loss to profitability is generally seen as a positive sign, which would typically lead to an increasing share price. Despite the recent downturn, long-term shareholders have made an annual gain of 18% over half a decade. If the fundamental data continues to indicate long term sustainable growth, the current sell-off could be an opportunity worth considering.
Scott Sutton's recent sale of Olin shares is the largest insider sale in the past year. The sale's timing, around the current price, is neither alarming nor encouraging. The absence of insider purchases over the year and low insider ownership raise caution about the company.
1
Olin's diminishing earnings predict a possible decline in the P/E ratio. Investors see a low potential for earnings improvement, suggesting share price might not increase extensively in the near future.
Morning Movers
Gapping up
$美國超微公司(AMD.US$ Shares of the chipmaker rose 2% in premarket trading as investors digested the details of the new Instinct MI300X product that AMD unveiled on Wednesday afternoon. The chip is designed to take advantage of the boom in demand for computing power from artificial intelligence.
$捷藍航空(JBLU.US$ on Thursday narrowed its annual adjusted loss forecast, riding on st...
Gapping up
$美國超微公司(AMD.US$ Shares of the chipmaker rose 2% in premarket trading as investors digested the details of the new Instinct MI300X product that AMD unveiled on Wednesday afternoon. The chip is designed to take advantage of the boom in demand for computing power from artificial intelligence.
$捷藍航空(JBLU.US$ on Thursday narrowed its annual adjusted loss forecast, riding on st...
12
1
閱讀更多